Zitieren

1. Kragh-Hansen U, Chuang VT, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull 2002; 25: 695-704.10.1248/bpb.25.695Search in Google Scholar

2. Bertucci C, Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem 2002; 9: 1463-1481.10.2174/0929867023369673Open DOISearch in Google Scholar

3. Kandagal PB, Ashoka S, Seetharamappa J, Shaikh S, Jadegoud Y, Ijare OB. Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J Pharm Biomed Anal 2006; 41: 393-399.10.1016/j.jpba.2005.11.037Search in Google Scholar

4. Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 1975; 11: 824-832.Search in Google Scholar

5. Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 1976; 12: 1052-1061.Search in Google Scholar

6. Zhang LW, Wang K, Zhang XX. Study of the interactions between fluoroquinolones and human serum albumin by affinity capillary electrophoresis and fluorescence method. Anal Chim Acta 2007; 603: 101-110.10.1016/j.aca.2007.09.021Search in Google Scholar

7. Zhanel GG, Homenuik K, Nichol K, et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs 2004; 64: 63-88.10.2165/00003495-200464010-00005Open DOISearch in Google Scholar

8. Fey G, Reiss M, Kersten H. Interaction of tetracylines with ribosomal subunits from Escherichia coli. A fluorometric investigation. Biochemistry 1973; 12: 1160-1164.10.1021/bi00730a022Search in Google Scholar

9. Townsend ML, Pound MW, Drew RH. Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag 2007; 3: 1059-1070.Search in Google Scholar

10. MacManus-Spencer LA, Tse ML, Hebert PC, Bischel HN, Luthy RG. Binding of perfluorocarboxylates to serum albumin: a comparison of analytical methods. Anal Chem 2010; 82: 974-981.10.1021/ac902238uSearch in Google Scholar

11. Bi S, Song D, Tian Y, Zhou X, Liu Z, Zhang H. Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim. Acta A Mol Biomol Spectrosc 2005; 61: 629-636.10.1016/j.saa.2004.05.028Search in Google Scholar

12. Stojanović SD, Janković SM, Matović ZD, Jakovljević IŽ, Jelić R.M. Interaction between tigecycline and human serum albumin in aqueous solution. Monatsh Chem 2015; 146: 399-409.10.1007/s00706-014-1330-6Search in Google Scholar

13. Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994; 45: 153-203.10.1016/S0065-3233(08)60640-3Search in Google Scholar

14. Sudhamalla B, Gokara M, Ahalawat N, Amooru DG, Subramanyam R. Molecular dynamics simulation and binding studies of beta-sitosterol with human serum albumin and its biological relevance. J Phys Chem B, 2010; 114: 9054-9062.10.1021/jp102730p20565066Search in Google Scholar

15. Chen T, Cao H, Zhu S, et al. Investigation of the binding of Salvianolic acid B to human serum albumin and the effect of metal ions on the binding. Spectrochim. Acta A Mol Biomol Spectrosc 2011; 81: 645-652.10.1016/j.saa.2011.06.06821782496Search in Google Scholar

16. Lakowicz JR. Principles of Fluorescence Spectroscopy. 3rd ed, New York, Plenum Press, 2006.10.1007/978-0-387-46312-4Search in Google Scholar

17. Eftink M R. Fluorescence Quenching: Theory and Applications. Top Fluoresc Spectrosc 2002; 2: 53−126.10.1007/0-306-47058-6_2Search in Google Scholar

18. Zhang HM, Fei ZH, Tang BP, Chen J, Tao WH, Wang Y.Q. The interaction of blood proteins with brucine. Mol Biol Rep 2012; 39: 4937-4947.10.1007/s11033-011-1289-x22160569Search in Google Scholar

19. Liu B, Zhao F, Xue C, Wang J, Lu Y. Studies on the antagonistic action between chloramphenicol and quinolones with presence of bovine serum albumin by fluorescence spectroscopy. J Lumin 2010; 130: 859-864.10.1016/j.jlumin.2009.12.014Search in Google Scholar

20. Sandhya B, Hedge AH, Ramesh KC, Seetharamappa J. Exploring the binding mechanism of ondansetron hydrochloride to serum albumins: spectroscopic approach. Spectrochim Acta A Mol Biomol Spectrosc 2012; 86: 410-416.10.1016/j.saa.2011.10.06022112579Search in Google Scholar

21. Cao H, Liu Q. Effects of temperature and common ions on binding of puerarin to BSA. J Solution Chem 2009; 38: 1071-1077.10.1007/s10953-009-9430-3Search in Google Scholar

22. Otagiri M. A molecular functional study on the interactions of drugs with plasma proteins. Drug Metab Pharmacokinet 2005; 20: 309–323.10.2133/dmpk.20.30916272748Search in Google Scholar

23. Tesseromatis C, Alevizou A. The role of the proteinbinding on the mode of drug action as well the interactions with other drugs. Eur J Drug Metab Pharmacokinet 2008; 33: 225–230.10.1007/BF0319087619230595Open DOISearch in Google Scholar

24. Bi S, Song D, Tian Y, Zhou X, Liu Z, Zhang H. Molecular spectroscopic study on the interaction of tetracy clines with serum albumins. Spectrochim. Acta A Mol Biomol Spectrosc 2005; 61: 629-636.10.1016/j.saa.2004.05.028Search in Google Scholar

25. Peterson FC, Anderson PJ, Berliner LJ, Brooks CL. Expression, folding, and characterization of small proteins with increasing disulfide complexity by a pT7-7-derived phagemid. Protein Expr Purif 1999; 15: 16-23.10.1006/prep.1998.0984Search in Google Scholar

26. Wen MG, Zhang XB, Tian JN, et al. Binding interaction of xanthoxylin with bovine serum albumin. J Solution Chem 2009; 38: 391-401.10.1007/s10953-009-9385-4Search in Google Scholar

27. Wang N, Ye L, Zhao BQ, Yu JX. Spectroscopic studies on the interaction of efonidipine with bovine serum albumin. Braz J Med Biol Res 2008; 41: 589-595.10.1590/S0100-879X2008000700007Open DOISearch in Google Scholar

28. Seetharamappa J, Kamat BP. Study of the interaction between fluoroquinolones and bovine serum albumin. J Pharm Biomed Anal 2005; 39: 1046-1050.10.1016/j.jpba.2005.05.013Search in Google Scholar

29. Tarushi A, Polatoglou E, Kljun J, Turel I, Psomas G, Kessissoglou DP. Interaction of Zn(II) with quinolone drugs: structure and biological evaluation. Dalton Trans 2011; 40: 9461-9473.10.1039/c1dt10870kSearch in Google Scholar

30. Hu YJ, Yang YO, Bai AM, Li W, Liu Y. Investigation of the interaction between ofloxacin and bovine serum albumin: spectroscopic approach. J Solution Chem 2010; 39; 709-717.10.1007/s10953-010-9527-8Search in Google Scholar

31. Živec P, Perdih F, Turel I, Giester G, Psomas G. Different types of copper complexes with the quinolone antimicrobial drugs ofloxacin and norfloxacin: structure, DNA- and albumin-binding. J Inorg Biochem 2012; 117: 35-47.10.1016/j.jinorgbio.2012.08.008Search in Google Scholar

32. Donovan JW, Changes in ultraviolet absorption produced by alteration of protein conformation. J Biol Chem 1969; 244: 1961-1967.10.1016/S0021-9258(18)94353-XSearch in Google Scholar

33. Wang YQ, Tang BP, Zhang HM, Zhou QH, Zhang GC. Studies on the interaction between imidacloprid and human serum albumin: spectroscopic approach. J Photochem Photobiol B 2009; 94: 183-190.10.1016/j.jphotobiol.2008.11.01319126446Search in Google Scholar

34. Seedher N, Agarwal P. Competitive binding of fluoroquinolone antibiotics and some other drugs to human serum albumin: a luminescence spectroscopic study. Luminescence 2013; 28: 562-568.10.1002/bio.249423436490Open DOISearch in Google Scholar

35. Seedher N, Agarwal P. Complexation of fluoroquinolone antibiotics with human serum albumin: a fluorescence quenching study. J Lumin 2010; 130: 1841-1848.10.1016/j.jlumin.2010.04.020Search in Google Scholar

36. Xiao J, Chen L, Yang F, Liu C, Bai Y. Green, yellow and red emitting CdTe QDs decreased the affinities of apigenin and luteolin for human serum albumin in vitro. J Hazard Mater 2010; 182: 696-703.10.1016/j.jhazmat.2010.06.08820633991Search in Google Scholar

37. Brunton L, Lazo J, Parker K. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th ed., New York, McGraw-Hill, 2005.10.1345/aph.1G685Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
4 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, andere